“`html
CDC Vaccine Panel Delays Hepatitis B Vote Amidst Growing Anti-Vaccine Influence
A growing wave of vaccine hesitancy and political influence has culminated in a delayed vote on infant hepatitis B vaccinations, raising concerns about the future of public health recommendations. On Thursday, advisors for the US centers for Disease Control and prevention (CDC) voted six to three to postpone a decision on restricting the hepatitis B vaccine for newborns, citing a need for further review of the proposed wording.
The meeting of the Advisory Committee on Immunization Practices (ACIP) was marked by tension and disagreement, culminating in the motion to delay. This unprecedented debate over restricting access to a decades-old,demonstrably safe vaccine underscores a broader trend of questioning established immunization protocols.
No new evidence suggesting harm from the hepatitis B vaccine – which has been administered to 1.4 billion people over more than three decades with a strong safety record – was presented during the meeting. Currently, the vaccine is universally recommended at birth for all infants in the United States. Despite this, several committee members pressed for evidence of harm, while together highlighting the vaccine’s benefits. one advisor noted that the vice-chair presiding over the meeting at times interrupted those advocating for the vaccine’s continued use.
The composition of the ACIP has drawn scrutiny, with reports indicating that several members were appointed by Robert F. Kennedy Jr., the former health secretary under Donald Trump and a well-known anti-vaccine advocate. Thes appointments have fueled concerns that the committee’s recommendations are increasingly influenced by ideological opposition to vaccination.
This stalled vote follows recent ACIP meetings where advisors recommended restricting access to Covid vaccines, as well as vaccines for measles, mumps, rubella, and chickenpox – decisions that have complicated vaccine guidance for both families and healthcare providers. Kennedy has long advocated for delaying the hepatitis B shot, and experts warn that any alteration to the current vaccination schedule could have significant repercussions for childhood health across the US.
The leadership of the ACIP underwent a change earlier this week, with Martin Kulldorff transitioning to the US Department of Health and Human Services (HHS).He was replaced as chair by Kirk Milhoan, a pediatric cardiologist who has publicly opposed Covid vaccines and promoted the use of ivermectin, a drug ineffective against parasitic infections.
data from a 2023 study published in the official journal of the US surgeon general demonstrates the effectiveness of the current vaccination program.The study revealed a 99% decline in reported cases of acute hepatitis B among children, adolescents, and young adults between 1990 and 2019, directly attributable to infant immunization.
In September, the panel voted to alter US vaccine policy, recommending multiple vaccines to protect against measles, mumps, rubella, and chickenpox, rather than a single combination vaccine. The following day, the panel voted against recommending a prescription requirement for the Covid-19 vaccine.
The ACIP’s recommendations are ultimately advisory, directed to the head of the CDC, currently acting director Jim O’Neill. The previous director, Susan Monarez, was removed by the Trump administration in August, with the White House stating she was “not aligned” with the president’s agenda.
Amidst a rise in vaccine hesitancy – a trend exacerbated by the coronavirus pandemic – childhood immunization rates are declining across the United States. The US is projected to be among dozens of countries reporting
